-
Osimertinib plus chemo beat chemo alone in patients with advanced EGFR-mutated NSCLC who advanced on first-line osimertinib
Experts said the results of the COMPEL trial support continued treatment with osimertinib beyond progression in this patient population.
Recent News
-
Small steps toward a noninvasive approach to pulmonary hypertension
Noninvasive imaging approaches, particularly echocardiography-based and CT scan-based main pulmonary artery diameter assessment, offer complementary insights into early PH detection and risk stratification.
-
Closing the gap in pulmonary rehabilitation
If pulmonary rehabilitation in the United States is going to meet the scale of need in coming years, it must grow consistently, equitably, and sustainably.
-
Viloxazine-trazodone combo shows promise for OSA relief
Investigator Ludovico Messineo, MD, PhD, said lower dosages will need to be tested to ensure that the beneficial effects on OSA severity are maintained while minimizing side effects.
-
Azelastine nasal spray shows promise in preventing SARS-CoV-2 infections
Researcher Robert Bals, MD, PhD, said this is a starting point, a signal of efficacy that warrants confirmation in larger, multicentric, phase 3 trials.
-
No benefit found for conservative oxygen therapy for adults who are critically ill
While the approach did not outperform usual therapy, it was not inferior to standard treatment either, suggesting additional studies of SpO2 goals are warranted.
-
Revolutionizing respiratory care: Bedside ultrasound for diaphragm assessment
Diaphragm ultrasound is a safe, noninvasive tool that evaluates respiratory muscle function, aiding in diagnosis, weaning from ventilation, and management of lung disease.
